pRED

Roche pRED transforms world-class science into medicine through a diversity of technologies and talent located across seven research sites worldwide.

Our organization consists of more than 2,200 scientists and clinicians working across the globe, from Europe to North America and Asia.

pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day.

Our pipeline typically has 30 to 40 new molecular entities in development from Phase 0 to Phase II trials.